Tandem Diabetes Care, Inc. Operating Lease, Payments
Tandem Diabetes Care, Inc. (TNDM) reported Operating Lease, Payments of $20.20 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-19.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:OperatingLeasePayments · last filed 2026-02-19
- Tandem Diabetes Care, Inc. operating lease, payments for the quarter ending 2023-12-31 was $4.70M, a 83.59% increase year-over-year.
- Tandem Diabetes Care, Inc. operating lease, payments for the quarter ending 2023-09-30 was $4.80M, a 37.14% increase year-over-year.
- Tandem Diabetes Care, Inc. operating lease, payments for the quarter ending 2023-06-30 was $2.60M, a 4.00% increase year-over-year.
- Tandem Diabetes Care, Inc. operating lease, payments for the quarter ending 2023-03-31 was $1.80M, a 47.06% decline year-over-year.
- Tandem Diabetes Care, Inc. operating lease, payments for fiscal 2025 was $20.20M, a 12.85% increase from fiscal 2024.
- Tandem Diabetes Care, Inc. operating lease, payments for fiscal 2024 was $17.90M, a 28.78% increase from fiscal 2023.
- Tandem Diabetes Care, Inc. operating lease, payments for fiscal 2023 was $13.90M, a 16.22% increase from fiscal 2022.
- Tandem Diabetes Care, Inc. operating lease, payments for fiscal 2022 was $11.96M, a 26.40% increase from fiscal 2021.
| Period end | Operating Lease, Payments 3 month | Operating Lease, Payments 6 month | Operating Lease, Payments 9 month | Operating Lease, Payments 9 month as first filed | Operating Lease, Payments 12 month | Operating Lease, Payments 12 month as first filed |
|---|---|---|---|---|---|---|
| 2025-12-31 | $20.20M 10-K · filed 2026-02-19 | |||||
| 2024-12-31 | $17.90M 10-K · filed 2026-02-19 | $17.94M 10-K · filed 2025-02-26 | ||||
| 2023-12-31 | $4.70M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $9.50M derived: sum of 2 quarters · filed 2026-02-19 | $12.10M derived: sum of 3 quarters · filed 2026-02-19 | $13.90M 10-K · filed 2026-02-19 | $13.86M 10-K · filed 2024-02-21 | |
| 2023-09-30 | $4.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-01 | $7.40M derived: sum of 2 quarters · filed 2023-11-01 | $9.20M 10-Q · filed 2023-11-01 | $11.76M derived: sum of 4 quarters · filed 2025-02-26 | ||
| 2023-06-30 | $2.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $4.40M 10-Q · filed 2023-08-03 | $6.96M derived: sum of 3 quarters · filed 2025-02-26 | $10.46M derived: sum of 4 quarters · filed 2025-02-26 | ||
| 2023-03-31 | $1.80M 10-Q · filed 2023-05-03 | $4.36M derived: sum of 2 quarters · filed 2025-02-26 | $7.86M derived: sum of 3 quarters · filed 2025-02-26 | $10.36M derived: sum of 4 quarters · filed 2025-02-26 | ||
| 2022-12-31 | $2.56M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26 | $6.06M derived: sum of 2 quarters · filed 2025-02-26 | $8.56M derived: sum of 3 quarters · filed 2025-02-26 | $11.96M 10-K · filed 2025-02-26 | $16.70M 10-K · filed 2023-02-22 | |
| 2022-09-30 | $3.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-01 | $6.00M derived: sum of 2 quarters · filed 2023-11-01 | $9.40M 10-Q · filed 2023-11-01 | $11.76M derived: sum of 4 quarters · filed 2024-02-21 | ||
| 2022-06-30 | $2.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $5.90M 10-Q · filed 2023-08-03 | $8.26M derived: sum of 3 quarters · filed 2024-02-21 | $10.66M derived: sum of 4 quarters · filed 2024-02-21 | ||
| 2022-03-31 | $3.40M 10-Q · filed 2023-05-03 | $5.76M derived: sum of 2 quarters · filed 2024-02-21 | $8.16M derived: sum of 3 quarters · filed 2024-02-21 | $10.56M derived: sum of 4 quarters · filed 2024-02-21 | ||
| 2021-12-31 | $2.36M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-21 | $4.76M derived: sum of 2 quarters · filed 2024-02-21 | $7.16M derived: sum of 3 quarters · filed 2024-02-21 | $9.46M 10-K · filed 2024-02-21 | $9.50M 10-K · filed 2022-02-22 | |
| 2021-09-30 | $2.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-02 | $4.80M derived: sum of 2 quarters · filed 2022-11-02 | $7.10M 10-Q · filed 2022-11-02 | $9.90M derived: sum of 4 quarters · filed 2023-02-22 | ||
| 2021-06-30 | $2.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-03 | $4.70M 10-Q · filed 2022-08-03 | $7.50M derived: sum of 3 quarters · filed 2023-02-22 | $10.00M derived: sum of 4 quarters · filed 2023-02-22 | ||
| 2021-03-31 | $2.30M 10-Q · filed 2022-05-04 | $5.10M derived: sum of 2 quarters · filed 2023-02-22 | $7.60M derived: sum of 3 quarters · filed 2023-02-22 | $8.90M derived: sum of 4 quarters · filed 2023-02-22 | ||
| 2020-12-31 | $2.80M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-22 | $5.30M derived: sum of 2 quarters · filed 2023-02-22 | $6.60M derived: sum of 3 quarters · filed 2023-02-22 | $8.20M 10-K · filed 2023-02-22 | ||
| 2020-09-30 | $2.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03 | $3.80M derived: sum of 2 quarters · filed 2021-11-03 | $5.40M 10-Q · filed 2021-11-03 | $5.90M 10-Q · filed 2020-11-05 | $6.70M derived: sum of 4 quarters · filed 2021-11-03 | |
| 2020-06-30 | $1.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-04 | $2.90M 10-Q · filed 2021-08-04 | $4.20M derived: sum of 3 quarters · filed 2021-08-04 | $5.30M derived: sum of 4 quarters · filed 2021-08-04 | ||
| 2020-03-31 | $1.60M 10-Q · filed 2021-05-05 | $2.90M derived: sum of 2 quarters · filed 2021-05-05 | $4.00M derived: sum of 3 quarters · filed 2021-05-05 | $5.10M derived: sum of 4 quarters · filed 2021-05-05 | ||
| 2019-12-31 | $1.30M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24 | $2.40M derived: sum of 2 quarters · filed 2021-02-24 | $3.50M derived: sum of 3 quarters · filed 2021-02-24 | $4.40M 10-K · filed 2021-02-24 | $4.30M 10-K · filed 2020-02-24 | |
| 2019-09-30 | $1.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $2.20M derived: sum of 2 quarters · filed 2020-11-05 | $3.10M 10-Q · filed 2020-11-05 | |||
| 2019-06-30 | $1.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-30 | $2.00M 10-Q · filed 2020-07-30 | ||||
| 2019-03-31 | $900.00K 10-Q · filed 2020-04-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B |